中国药物警戒 ›› 2013, Vol. 10 ›› Issue (6): 334-336.

• 政策与法规研究 • 上一篇    下一篇

我国基本药物制度与药品不良反应监测关系的探讨

刘翠丽,侯永芳,宋秋杰,田春华*   

  1. 国家食品药品监督管理总局药品评价中心,北京 100045
  • 收稿日期:2013-04-23 修回日期:2016-03-09 出版日期:2013-06-08 发布日期:2016-03-09
  • 通讯作者: 田春华,女,副主任药师,基本药物不良反应监测与评价。 E-mail:tianchunhua@cdr.gov.cn
  • 作者简介:刘翠丽,女,主管药师,基本药物不良反应监测与评价。

Di scussion on the Relationship between National Essential Medicine System and Adverse Drug Reaction Monitoring

LIU Cui-li ,HOU Yong-fang ,SONG Qiu-jie, TIAN Chun-hua   

  1. Center for Drug Reevalutaion,CFDA, Beijing 100045, China
  • Received:2013-04-23 Revised:2016-03-09 Online:2013-06-08 Published:2016-03-09

PDF (PC)

143

摘要： 2012年版《国家基本药物目录》的正式发布,预示着我国国家基本药物制度进入一稳定发展时期。在基本药物制度实施过程中,药品不良反应监测作为常规手段保障了基本药物制度的顺利实施；同时,基本药物制度也促进了药品不良监测工作的发展。本文通过对我国基本药物制度和药品不良反应监测关系的探讨,强调了二者在发展过程中互相影响、互相促进的关系。

关键词: 基本药物制度, 药品不良反应监测, 关系

Abstract: Abastract: The formally releasing of 2012 edition of National Essential Medicine List indicates that the work of Chinese national system for essential medicines into the stable development of the new period. In the implementation of essential medicine system process, adverse drug reaction(ADR) monitoring is a routine measure to ensure the smooth implementation of essential medicine system, at the same time, the essential medicine system also promotes the development of ADR monitoring work. Through introducing the relationship between the essential medicine system and the ADR monitoring in China, the relationship between them is mutual influence and promotion in the process of development.

Key words: essential medicine system, the adverse reaction monitoring, relationship

中图分类号: